Status:
UNKNOWN
Therapeutic Plasmapheresis in Critically Ill Adult Patients With COVID-19 Confirmed Diagnosis
Lead Sponsor:
Fundación Cardiovascular de Colombia
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Introduction: The SARS-CoV-2 outbreak has left more than two million infected worldwide in the first four months of COVID-19 epidemic. To date, there is no specific treatment for the disease and in cr...
Eligibility Criteria
Inclusion
- Age range: Over 18 years old
- Patients with confirmed infection by COVID-19 (positive real-time PCR) in ICU with:
- Respiratory failure receiving ventilatory support and high parameters
- Severe pneumonia with rapid progression
- Ability to sign informed consent
Exclusion
- Pregnant women
- Contraindication of plasma administration due to history of anaphylaxis during transfusions
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2022
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT04480632
Start Date
August 1 2020
End Date
August 1 2022
Last Update
July 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Internacional de Colombia
Piedecuesta, Santander Department, Colombia